When marked for degradation, surface receptor and transporter proteins are internalized and delivered to endosomes where they are packaged into intralumenal vesicles (ILVs). Many rounds of ILV formation create multivesicular bodies (MVBs) that fuse with lysosomes exposing ILVs to hydrolases for catabolism. Despite being critical for protein degradation, the molecular underpinnings of MVB-lysosome fusion remain unclear, although machinery underlying other lysosome fusion events is implicated. But how then is specificity conferred? And how is MVB maturation and fusion coordinated for efficient protein degradation? To address these questions, we developed a cell-free MVB-lysosome fusion assay using Saccharomyces cerevisiae as a model. After confirming that the Rab7 ortholog Ypt7 and the multisubunit tethering complex HOPS (homotypic fusion and vacuole protein sorting complex) are required, we found that the Qa-SNARE Pep12 distinguishes this event from homotypic lysosome fusion. Mutations that impair MVB maturation block fusion by preventing Ypt7 activation, confirming that a Rabcascade mechanism harmonizes MVB maturation with lysosome fusion.
| INTRODUCTION
Endocytosis regulates surface expression levels of polytopic proteins such as transporters and receptors for cellular signaling and survival in all eukaryotic organisms. Proteins destined for degradation are labeled with ubiquitin and cleared from the surface by invagination and scission of the plasma membrane. Through membrane fusion events, newly formed endocytic vesicles deliver cargo proteins to endosomal membranes where they encounter ESCRTs (endosomal sorting complexes required for transport) that sorts them into intraluminal vesicles (ILVs). Many rounds of ILV formation produce a multivesicular body (MVB) 1, 2 that when mature fuses with the lysosome exposing ILVs to lumenal hydrolases for catabolism. [3] [4] [5] Although critical for surface protein degradation, we still do not understand many aspects of this terminal step of the endocytic pathway in molecular detail.
However, based on results primarily acquired using genetic approaches and microscopy, a model has emerged describing the mechanisms underlying MVB-lysosome fusion that are thought to be conserved in all eukaryotic species. 5, 6 MVBs contain 2 paralogs of almost every component of the fusion machinery. 7 One set (the Rab5 module) is required for endosome membrane fusion events responsible for anterograde membrane trafficking to the MVB, for surface protein delivery and organelle biogenesis. The second set (Rab7 module) is proposed to mediate MVB-lysosome fusion. However, most components of the latter set also drive homotypic lysosome fusion, 8, 9 provoking the question: What distinguishes these 2 fusion events?
Because the underlying machinery is similar, inferences into the molecular basis of MVB-lysosome fusion have been drawn from detailed knowledge of the homotypic lysosome membrane fusion reaction, largely elucidated by studying Saccharomyces cerevisiae and its vacuolar lysosome (or vacuole), as models. Advances in this area were primarily driven by the use of reliable, quantitative cell-free membrane fusion assays to study homotypic vacuole fusion. 10, 11 This powerful biochemical approach has revealed 4 distinct subreactions required for organelle membrane fusion and the critical players for each that presumably mediate MVB-vacuole fusion as well.
Priming, the first subreaction, requires Sec18, an NSF (N-ethylmaleimide-sensitive factor) ortholog and homohexameric ATPase, and Sec17, an α-SNAP (soluble NSF attachment protein) ortholog and protein chaperone, to unravel cis-SNARE (SNAP REceptor) complexes from previous fusion events to free up individual SNARE proteins for future rounds of membrane fusion. 12, 13 As the only α-SNAP and NSF orthologs in S. cerevisiae, Sec17 and Sec18 are thought to mediate all SNARE-mediated membrane fusion events in the cell, but their roles in MVB-vacuole fusion have not been investigated. Afterwards (or possibly concomitantly), organellar membranes undergo tethering, the second subreaction, whereby apposing membranes make first contact. This requires activation of the Rab-GTPase Ypt7 (a Rab7 ortholog) and interaction with its cognate multisubunit tethering complex (MTC) called HOPS (homotypic fusion and vacuole protein sorting complex). 14, 15 Next, fusogenic proteins (eg, Sec17, Ypt7, HOPS and SNAREs) and lipids are recruited to the initial contact site where they assemble into an expanding ring at the vertex between adjacent organelles. [16] [17] [18] Called docking, this subreaction also includes the formation of trans-SNARE protein complexes mediated by HOPS. 19, 20 Like homotypic lysosome fusion, Ypt7 and HOPS accumulate at contact sites between MVB and vacuole membranes in S. cerevisiae. 21 Furthermore, depleting components of HOPS impairs delivery of endocytic cargoes to vacuoles in yeast or lysosomes in human cells. 22, 23 Thus both Ypt7 and HOPS are implicated in MVB-vacuole fusion where they presumably contribute to tethering and docking. 6, [24] [25] [26] During the last fusion subreaction, trans-SNARE complexes containing 3 Q-SNAREs (Qa, Qb and Qc donated from 1 membrane) and 1 R-SNARE (from the apposing membrane) fully zipper driving lipid bilayer merger. 27 Two of four SNAREs within the complex that mediates homotypic lysosome fusion are also found on MVB membranes: the Qb-SNARE Vti1 and soluble Qc-SNARE Vam7. 28, 29 Otherwise, the MVB expresses its own paralogs of the Qa-SNARE, Pep12 in place of Vam3 on the vacuolar lysosome, and the R-SNARE Snc2 in place of Nyv1. 30, 31 The SNAREs donated by each organelle to the complex that drives MVB-lysosome fusion are unknown. Thus, it is possible that the MVB donates either Q-SNAREs including Pep12 or the R-SNARE Snc2 to SNARE complexes distinguishing MVB-lysosome from homotypic lysosome fusion.
Recognizing the impact these cell-free assays have had on our understanding of homotypic lysosome fusion, we developed a similar method to reliably measure MVB-lysosome membrane fusion in To confirm that the fusion probes were properly localized within cells, we generated yeast strains expressing versions of the probes tagged with variants of GFP at their C-termini, stained them with FM4-64 to label vacuole membranes and imaged them using fluorescence microscopy ( Figure 1B ). The Pep12-GFP fusion protein appeared on puncta consistent with MVB localization as reported previously, 32 whereas the CPY50-GFP fusion protein was found within the vacuole lumen. Next, we fractionated cellular membranes by sucrose gradient ( Figure S1A ) and used western blot analysis to confirm that Pep12-Fos-Gs-ω is found in similar fractions (9-12) as Vps10, a resident protein on MVBs, 33 as well as endogenous Pep12.
CPY50-Jun-Gs-α is not found in fractions containing the MVB fusion probe, but rather in fractions three and four containing Nyv1, a R-SNARE that is exclusively found on vacuole membranes, 34 and endogenous CPY, a vacuole resident protein. We next collected fractions containing MVB membranes (fractions 9-12) from Pep12-Fos-Gs-ω expressing cells or vacuole membranes (fractions 3, 4) from CPY50-Jun-Gs-α expressing cells and mixed them together under conditions that promote the homotypic vacuole membrane fusion reaction in vitro. 11 Unfortunately, these preparations were fusion incompetent ( Figure S1B ). Thus, we sought an alternative method to isolate the organelles to optimize our cell-free fusion assay.
Based on a method to isolate intact, fusogenic vacuoles from yeast cells, 35 we decided to use a 4-step ficoll gradient to isolate both MVBs and vacuoles in the same preparations. Although vacuoles are known to accumulate at the 0% to 4% ficoll interface, it is not clear whether MVBs also migrate to this layer during centrifugation. Thus, we performed ficoll-based fractionation experiments using cells expressing GFP-tagged versions of the fusion probes, collected organelles that accumulated at the 0% to 4% ficoll interface, and imaged them by fluorescence microscopy ( Figure 1C ). Pep12-GFP is present in the preparation and localizes to small puncta adjacent to vacuole membranes reminiscent of MVB structures, whereas CPY50-GFP is found within the lumen of isolated vacuoles, consistent with their distributions in living cells. We then imaged these organelle preparations using transmission electron microscopy (TEM) and observed structures resembling MVBs, some of which were in close contact with vacuole membranes, a prerequisite for fusion ( Figure 1D ). 36 We also observed the presence of our fusion probes (Pep12-Fos-Gs-ω or CPY50-Jun-Gs-α) in this fraction by western blot analysis ( Figure 1E ). Markers of both MVBs (Vps10, endogenous Pep12) and vacuoles (Nyv1, endogenous CPY) and fusogenic proteins (eg, Ypt7, Vps41, Vps33 and Nyv1) were also present confirming that both organelles are found in this preparation and are likely fusogenic. (Figure 2A ), which predicts that Sec17, Ypt7 and HOPS orchestrate this event. 6, 37 The α-SNAP ortholog Sec17 both unravels cis-SNARE complexes and, through HOPS binding, promotes SNARE-zippering during homotypic fusion. 9, 27 As the only α-SNAP ortholog in S. cerevisiae, it is hypothesized to also play a role in MVBvacuole fusion. Indeed, adding purified anti-Sec17 antibody, at concentrations that block homotypic fusion, also prevents heterotypic fusion ( Figure 2B ), suggesting a role in both events. We next confirmed that Ypt7 and HOPS (the Rab7 module in yeast) also underlie both fusion events ( Figure 2B ): Addition of the Rab-GTPase inhibitors rGdi1 (a Rab-GTPase chaperone that extracts Rab proteins from membranes) or rGyp1-46 (the active domain of the Rab-GAP protein Gyp1 38 ) blocks both fusion events, confirming that Rab-GTPase activation is required. Addition of purified anti-Ypt7 antibody, at levels that block homotypic fusion, inhibited heterotypic fusion, confirming that activation of this specific Rab is needed for both fusion events.
The HOPS holocomplex contains 6 protein subunits, 2 of which are unique (Vps41 and Vps39) and 4 (Vps33, Vps11, Vps18 and Vps16) that are shared with CORVET (class C core vacuole/endosome tethering complex), a similar MTC within the Rab5 module also found on endosomes. [39] [40] [41] Addition of purified anti-Vps33 antibody blocks both fusion events ( Figure 2B ), suggesting involvement of either complex. Purified anti-Vps41 antibody also blocked heterotypic and homotypic fusion ( Figure 2B ), confirming that HOPS, specifically, contributes MVB-vacuole fusion.
| trans-SNARE complexes distinguish MVBvacuole from homotypic vacuole fusion events
The final stage of the organelle fusion reaction is lipid bilayer merger driven by complete trans-SNARE-complex zippering. 42 To test this hypothesis, we isolated SNARE complexes using an approach that ensures they form in trans during the membrane fusion reaction in vitro 19, 27 : We mixed organelles missing NVY1 and containing Pep12 fused to calmodulin-binding protein (CBP::Pep12) with organelles missing PEP12 under fusogenic conditions, and then conducted pull-down assays and western blot analysis to identify SNARE proteins in complex with CBP::Pep12 ( Figure 3A ). We also repeated the experiment with CBP::Vam3 for comparison and as a positive control. 27 As expected, both trans-SNARE complexes contained Vti1
and Vam7, but only under fusogenic conditions (with ATP; Figure 3B ). Very little Vma3 co-purified with CBP::Pep12, and no Pep12 was found in CBP::Vam3 complexes, confirming the presence of distinct Q-SNARE bundles. Importantly, the vacuolar R-SNARE Nyv1 was found in both complexes, but not the endosomal R-SNARE Snc2, confirming that Pep12-Vti1-Vam7-Nyv1 complexes form in trans during organelle fusion in vitro.
Addition of purified, recombinant Vam7 protein (rVam7, the soluble Qc-SNARE) to isolated vacuoles drives formation of vacuolar Reactions were kept on ice to prevent fusion as negative controls.
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trans-SNARE complexes promoting homotypic fusion without ATP. 44 Given that Vam7 is found in both trans-SNARE complexes, we next tested if rVam7 could also stimulate assembly of Pep12-containing complexes. As expected, rVam7 drives formation of both trans-SNARE complexes ( Figure 3B ), suggesting that it contributes to heterotypic as well as homotypic fusion. Vps33, a component of HOPS and SM-protein ortholog, binds SNAREs and initiates trans-SNARE complex formation during homotypic vacuole fusion by threading the Qa-SNARE Vam3 with the R-SNARE Nyv1. 45 Recombinant Vps33 protein was also shown to thread Pep12 and Nyv1 proteins in vitro. 46 Thus, we also tested whether Vps33 binds to trans-SNARE complexes thought to mediate MVB-vacuole fusion. Indeed, Vps33
bound to Pep12-Nyv1-containing as well as Vam3-Nyv1-containing complexes ( Figure 3B ), suggesting that HOPS initiates formation of Pep12-Vti1-Vam7-Nyv1 complexes in trans to drive MVB-vacuole fusion.
To demonstrate that this distinct trans-SNARE complex drives MVB-vacuole fusion, we next tested the role of these SNAREs in this process using our new in vitro assay. First, we added different purified antibodies raised against the Qa-SNAREs Pep12 or Vam3 to organelle fusion reactions ( Figure 3C ). As predicted, increasing concentrations of anti-Pep12 antibody preferentially blocked heterotypic fusion, whereas anti-Vam3 antibody preferentially inhibited homotypic fusion. Addition of purified anti-Nyv1 antibody or knocking out NYV1 blocked both fusion events, consistent with the presence of this R-SNARE in both complexes ( Figures 3D and S2 ). Moreover, when we mix mutant and wild type organelles, we find that heterotypic fusion is impaired only when vacuole membranes lack NVY1
( Figure 3E ), confirming that this R-SNARE is donated from the vacuole. To confirm that trans-SNARE complexes formed by the Qc-SNARE Vam7 mediate both MVB-vacuole and homotypic vacuole fusion, we next added rVam7 to isolated organelles in the absence of ATP ( Figure 3D ). As for homotypic fusion, 44 we found that addition of rVam7 is sufficient to stimulate MVB-vacuole fusion in vitro. Furthermore, addition of anti-Sec17 antibody to prevent unraveling of newly formed SNARE complexes 27 enhanced this effect, confirming that it contributes to heterotypic as well as homotypic fusion.
Together, these results demonstrate that the Pep12-Vti1-Vam7-Nyv1 trans-SNARE complex drives MVB-vacuole fusion, revealing that the composition of SNARE complexes distinguishes heterotypic from homotypic fusion events.
| ESCRTs activate Ypt7 for MVB-lysosome fusion
The ESCRT machinery mediates sorting and packaging of internalized surface proteins into ILVs creating the MVB. 47 Deleting components of ESCRTs prevents delivery of internalized surface proteins to vacuoles and causes them to accumulate on aberrant, enlarged endocytic compartments. [48] [49] [50] These observations led to the hypothesis that protein sorting and ILV formation by ESCRTs is necessary to trigger MVB-lysosome fusion. 51 To directly test this hypothesis, we individually knocked out single components of 3 ESCRTs (VPS23 in ESCRT-I, VPS36 in ESCRT-II and SNF7 in ESCRT-III) 47 in strains expressing the MVB fusion probe. After confirming the probe localized to aberrant endocytic compartments within these mutant cells ( Figure 4A ), 50, 52 we mixed organelles isolated from these strains with organelles from wild type cells expressing the vacuole fusion probe and conducted in vitro fusion assays ( Figure 4B ). This approach ensured that vacuoles were fusogenic, as deleting components of ESCRTs blocks the CPY and CPS (carboxypeptidase- 11, 36, 55 and found that it partially rescued heterotypic fusion defects caused by deleting components of ESCRTs ( Figure 4B ). Next, we added 100 nM rVam7 in place of ATP to stimulate fusion, as it bypasses the requirement for Ypt7, 44 and found that it also partially rescued fusion defects ( Figure 4B,D) . These results also confirm that Ypt7 and SNAREs are functional, but not engaged, on aberrant endosomal compartments isolated from ESCRT mutants. Finally, to demonstrate that Ypt7 is targeted, we introduced a Q68L mutation in YPT7 to render it constitutively active 56 in cells expressing the MVB fusion probe and lack VPS23. After confirming the fusion probe was properly localized, we found that it too rescued MVB-lysosome fusion defects caused by this mutation ( Figure 4A ,C). Addition of GTPγS did not further enhance heterotypic fusion in the presence of Ypt7 Q68L, suggesting that Ypt7 on the MVB membrane was the likely target of GTPγS that rescues fusion when ESCRT function is impaired. Furthermore, the mutation did not affect rVam7-driven fusion in the presence or absence of VPS23 ( Figure 4D ), confirming that Rab activity is bypassed under these conditions. In all, these findings demonstrate that disrupting the ESCRT machinery prevents Ytp7 activation on MVB membranes required for MVB-vacuole fusion. First, it is quantitative, robust (with a signal-to-noise ratio up to 10:1) and allows kinetic analysis. Second, it is a simple, colorimetric alternative to fluorescence-based assays limited by resolution and accuracy of co-localization methods offered by light microscopy (offering only 3:1 signal-to-noise ratio) 57 or assays that require use of radioactive reagents, for example, 125 I-labeled biotin (offering only 4:1 signal-to-noise ratio). 58 Third, it overcomes limitations associated with using genetic approaches to inhibit potential contributors to this event, whereby mutations hypothesized to block MVB-vacuole fusion also impair carboxypeptidase-Y and -S biosynthetic pathways that feed resident proteins to vacuoles, possibly introducing defects that affect fusogenicity in vivo. 48, 49 This is achieved by adding protein or small molecule inhibitors directly to fusion reactions containing organelles isolated from wild type cells or by mixing organelles isolated from mutants and wild type cells expressing complimentary probes; an approach that may also be used to define contributing mechanisms from each organelle. Fourth, It overcomes the need to purify organelles to homogeneity, as required to make inferences from alternative methods that do not selectively label a single organelle population, for example, lipid dyes (R-18) for fluorescence dequenching-based lipid-mixing fusion assays, 11 or internalized fluorescence dyes that label multiple endocytic compartments. 59 Fifth, unlike most cell-free endosome or MVB fusion assays, 60 it does not require addition of cytosol indicating that all machinery necessary for fusion co-purifies with organelles facilitating their study. Finally, it offers the advantages of changing the reaction buffer conditions to simulate changes in the "cytoplasm" to better understand how heterotypic fusion is regulated or using protein reagents to overcome issues associated with pleiotropy, allowing study of contributions from gene products predicted to have multiple functions at multiple sites in cells, for example, Sec17.
| A new model describing MVB-lysosome fusion
Here we definitively show that Sec17, Ypt7 and the HOPS complex are necessary for membrane fusion between MVBs and vacuoles ( Figure 2 ). These proteins also contribute to other fusion events in cells. 6, 7 Thus, deleting the genes encoding them induces pleiotropic phenotypes, including blockade of biosynthetic pathways to the vacuole. 22, 49 This work therefore lends important biochemical-based evidence to support the prevailing model describing the molecular underpinnings of MVB-vacuole fusion (Figures 2A and 4E ), which was almost exclusively backed by evidence generated using genetic approaches. 7 Moreover, we make an important advance in our understanding of this process:
A unique trans-SNARE complex distinguishes MVB-vacuole fusion from other vacuole fusion events. It differs from the complex that drives homotypic vacuole fusion whereby the Qa-SNARE Pep12 is donated from the MVB, in place of the vacuolar paralog Vam3, to form a Pep12-Vti1-Vam7-Nyv1 complex in trans ( Figure 3B ). As preassembled Q-SNARE bundles are donated from 1 membrane and RSNAREs from the other, 27 we propose that the MVB donates the Q-SNARE bundle Pep12-Vti1-Vam7 and the vacuole donates the R-SNARE Nyv1. We also demonstrate that these SNAREs are necessary or sufficient for MVB-vacuole fusion using 3 approaches ( Figure 3C -E): deleting NYV1 from vacuole membranes blocks fusion, adding purified antibodies raised against Nyv1 or Pep12 blocks fusion, or adding purified, recombinant Vam7 protein drives fusion. Importantly, we measure homotypic vacuole fusion as a control (Figures 1-3 ) to demonstrate that reagents used to target shared machinery are effective at the concentrations shown. We also exclude the possibility that the inverse trans-SNARE complex arrangement contributes to this process, that is, a complex containing the Qa-SNARE Vam3
(in complex with Vti1 and Vam7) from the vacuole and R-SNARE Snc2 donated by the MVB (Figure 3 ). These findings are consistent with numerous previous reports:
First, when Pep12-Vti1-Vam7-containing synthetic proteoliposomes are mixed with proteoliposomes expressing Nyv1, these Figure 3B ) and MVB-vacuole fusion requires Vps33 and Pep12 but not Vam3 ( Figures 2B and 3C ).
Thus, we conclude that Vps33 within the HOPS complex promotes
Pep12-Vti1-Vam7-Nyv1 complex formation in trans to drive MVBlysosome fusion ( Figure 4E ).
However, our findings are not entirely consistent with work published by Stevens and coworker who show that deleting NYV1 does not affect CPY delivery to the vacuole lumen which presumably requires MVB-vacuole fusion 64 (also see Figure S2 ). One possible explanation is that Ykt6, a lipid-anchored R-SNARE also found on vacuole membranes, compensates for the loss of Nyv1 by replacing it in SNARE complexes that drive this fusion event in living cells. 65 However, Ykt6 dissociates from isolated vacuole membranes, 66 possibly explaining why it does not replace Nyv1 to drive MVB-vacuole fusion in vitro. Furthermore, it is not clear whether Ykt6 efficiently complexes with Qa-SNARE bundles containing Pep12 or contributes to MVB-vacuole fusion. As far as we know, reliable antibodies raised against Ykt6 are unavailable and thus, we were unable to comprehensively test this hypothesis. However, we plan to address this issue in future studies that will determine if Ykt6 instead plays a role in fusion between vacuoles and other organelles.
| ESCRTs trigger MVB-lysosome fusion by promoting Rab conversion
Although they perform unique roles in polytopic protein sorting and packaging for degradation, deleting any ESCRT component causes formation of aberrant, enlarged endosomal structures called "class E compartments" to appear instead of proper MVBs. 50 Here, we show that individually deleting VPS23, VPS326 or SNF7-components of ESCRT-I, -II and -III, respectively-prevents fusion between these class E compartments and vacuoles in vitro ( Figure 4B ), consistent with observations that internalized surface proteins or biosynthetic cargoes (eg, CPY) are not efficiently delivered to vacuoles and accumulate on these aberrant structures. 67 Activating Ypt7 by introducing a Q68L mutation on the class E compartment membrane or adding GTPγS to reactions partially rescued fusion defects caused by deleting these ESCRT components ( Figure 4B,C) . Although it overcomes defects to support membrane fusion, it is unlikely that Ypt7Q68L allows recovery of protein sorting into ILVs or ILV formation in the absence of VPS23, because it does not play a role in this process. We therefore reason that protein sorting into ILVs and ILV formation act upstream to promote Ypt7 activation on mature MVB membranes, which in turn triggers fusion with vacuoles. 50 But how does this occur?
The precise molecular mechanism remains unknown, however, previous work revealed that active Vps21 and its GEF (guanine exchange factor) Vps9 accumulate on aberrant endosome membranes in cells lacking ESCRT function. 50 Although Ypt7 is present, its effector Vps41 (and presumably the HOPS complex) is absent from these compartments suggesting Ypt7 is not activated. These findings led to the hypothesis that a Rab conversion mechanism may couple MVB maturation with vacuole fusion, whereby upon completion of ESCRTdependent protein sorting into ILVs, Vps21 is inactivated, which in turn triggers activation of Ypt7 to promote fusion of the mature MVB with lysosomes. Vps9 is recruited to endosomal membranes by binding ubiquitin linked to internalized surface proteins. 68 Normally, these proteins are cleared from the perimeter membrane by ESCRTs, causing dissociation of Vps9 from the perimeter membrane and, in turn, Vps21
is inactivated linking MVB maturation to Rab conversion. However, ESCRT impairment causes ubiquitylated proteins to accumulate, Vps9 then remains and chronic activation of Vps21 prevent Rab conversion thus blocking MVB-vacuole fusion. 50, 68 Although the mechanism that couples Vps21 and Ypt7 activities remains elusive, it likely involves stimulation of Msb3, a GAP that inactivates Vps21, 69 Mon1-Ccz1, the GEF that activates Ypt7, 70 and possibly BLOC-1 (biogenesis of lysosome-like organelles complex-1) to coordinate GAP and GEF function on mature MVB membranes. 71 We will test this hypothesis in the near future using this new cell-free MVB-vacuole fusion assay to provide a comprehensive understanding of this process and to improve our knowledge of Rab conversion, which is thought to coordinate progressive membrane trafficking at most sites within eukaryotic cells.
As with the fusion machinery, ESCRTs and potential mediators of Vps21-Ypt7 conversion are evolutionarily conserved, suggesting the same mechanisms likely underlie MVB-lysosome fusion in metazoan cells. 72, 73 Loss-of-function mutations in ESCRT components are linked to many human disorders, including cancers and neurodegenerative diseases. 72 Similar to phenotypes observed in S. cerevisiae, enlarged, abnormal endosome-like structures accumulate and surface protein sorting and degradation is impaired within human cells harboring ESCRT mutations, 67 suggesting MVB-lysosome fusion is defective. Here we show that stimulating Ypt7, the yeast ortholog of human Rab7, overcomes this fusion defect. Although these compartments lack ILVs, this fusion event delivers internalized surface proteins to the vacuolar lysosome membrane where they could be selectively degraded by the intralumenal fragment (ILF) pathway. 74 As it is proposed that inefficient surface receptor degradation underlies the etiology of these diseases, we speculate that developing therapeutics designed to activate Rab7 may represent a valid strategy for treatment.
| MATERIALS AND METHODS

| Yeast strains and reagents
To prevent degradation, all fusion probes were expressed in BJ35050, a S. cerevisiae strain devoid of vacuolar lumenal proteases Recombinant Gdi1 protein was purified from bacterial cells using a calmodulin-binding peptide intein fusion system. 38 Recombinant
Gyp1-46 protein (the catalytic domain of the Rab-GTPase activating protein Gyp1) and recombinant Vam7 were purified as previously described. 14, 27 Reagents used in fusion reactions were prepared in 10 mM PIPES-KOH, pH 6.8 and 200 mM sorbitol (PIPES-sorbitol buffer, PS).
| Membrane fractionation by sucrose gradient
Yeast cells were grown in 1 L nutrient-rich growth media (YPD) overnight to OD 600 nm = 1.6/mL, harvested, and treated with lyticase for 30 minutes at 30 C. Spheroplasts were then sedimented and resuspended in 10 mL of TEA buffer (10 mM triethanolamine, pH 7.5, 100 mg/mL phenylmethylsulfonyl fluoride, 10 mM NaF, 10 mM NaN 3 , 1 mM EDTA and 0.8 M sorbitol) and Dounce homogenized on ice (20 strokes). Lysates were then centrifuged at 15 000g for 20 minutes, and the resulting supernatant was centrifuged at 100 000g for 2 hours to sediment cell membranes. Pellets were resuspended in 1 mL TEA buffer and loaded onto a stepwise (20%-70%) sucrose density gradient, and then centrifuged at 100 000g for 16 hours at 4 C to separate membranes by density. Samples were collected from the top, and each fraction was precipitated using 10% trichloroacetic acid, washed and resuspended in 100 μL SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) buffer.
Fractions were then loaded into SDS-polyacrylamide gels and subjected to electrophoresis to separate proteins by size. Western blot analysis was performed to determine fractions that contained proteins of interest.
| Organelle isolation and cell-free fusion assay
Organelles were isolated from yeast cells by ficoll floatation, as described previously. 10 Organelle membrane fusion was assessed using a modified version of a lumenal content-mixing assay that relies on reconstitution of β-lactamase activity. 11 In brief, organelles were Experimental results shown are calculated from at least 3 biological replicates, each repeated twice (6 technical replicates total).
| trans-SNARE pairing assay
trans-SNARE complex formation was assessed as previously described. 27 In brief, 45 μg of organelles isolated from BJ3505-CBP- 
| Fluorescence microscopy
Live yeast cells were stained with FM4-64 to label vacuole membranes using a pulse-chase method as described previously. 56 For in vitro imaging, organelles isolated from strains expressing Pep12-pHluorin or CPY50-GFP were stained with 3 μM FM4-64 for 
| Transmission electron microscopy
Isolated organelles were processed for TEM as described previously. 36 In brief, fusion reactions were incubated at 27 C for 30 minutes, organelles were gently pelleted (5000g for 5 minutes) at 
| Data analysis and presentation
All quantitative data were processed using Microsoft Excel v.14. 
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